SCHEMBL7418586

SCHEMBL7418586

Cc1ccc(F)cc1S(=O)(=O)N[C@@H](Cc1ccc(OCCCONC(=N)N)cc1)C(=O)OC(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
ITGB3 P05106 10/20 0.38
ITGA2B P08514 9/20 0.38
MEP1B Q16820 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
ITGB1 P05556 2/20 0.33
ITGAV P06756 1/20 0.33
ITGA5 P08648 1/20 0.33
F2 P00734 3/20 0.33
TMPRSS6 Q8IU80 3/20 0.33
IDH1 O75874 1/20 0.33
ITGA4 P13612 1/20 0.33
PTGES O14684 1/20 0.33
ALOX5 P09917 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
CA12 O43570 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410416 0.93 L3MBTL1 (0.41) CYP3A4CYP2C19ITGB3ITGA2BL3MBTL1
Trifluoroacetic Acid SCHEMBL7413938 0.90 ITGB3 (0.47) CYP3A4CYP2C19ITGB3ITGA2BL3MBTL1
SCHEMBL7415446 0.90 ITGB3 (0.39) CYP3A4CYP2C19ITGB3ITGA2BITGAV
SCHEMBL7418351 0.89 TYMS (0.37) ITGB3ITGA2BL3MBTL1ITGA4PPARG
SCHEMBL7408394 0.88 ITGB3 (0.37) CYP3A4CYP2C19ITGB3ITGA2BITGB1
SCHEMBL7413005 0.88 ITGB3 (0.50) CYP3A4CYP2C19ITGB3ITGA2BL3MBTL1
SCHEMBL7699209 0.87 F2 (0.42) ITGB3ITGA2BL3MBTL1F2TMPRSS6
SCHEMBL7412871 0.87 MEN1 (0.40) CYP3A4CYP2C19ITGB3ITGA2BITGB1
SCHEMBL7415207 0.87 ITGB3 (0.50) ITGB3ITGA2BITGAVF2TMPRSS6
SCHEMBL7422540 0.86 ITGB3 (0.42) ITGB3ITGA2BITGB1ITGAVITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed